Trials / Completed
CompletedNCT00130351
A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma
A 3-week Multicenter Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 155 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to investigate the ability of patients with asthma to properly use a new multi-dose dry powder inhaler (MDDPI) device in a real-life situation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | formoterol |
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2005-08-01
- Completion
- 2005-08-01
- First posted
- 2005-08-15
- Last updated
- 2023-05-19
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00130351. Inclusion in this directory is not an endorsement.